Skip to main content

Table 3 Characteristics of interview participants (n = 36)

From: The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in Australia

   Number of participants
Age group   
  18–29 years 1
  30–39 years 5
  40–49 years 8
  50–59 years 14
  60 years and over 8
Sex   
  Male 13
  Female 23
Stakeholder group   
  Rheumatologist 8
  Patient 6
  Government advisor 5
  Public servant 8
  Consumer representative 5
  Pharmaceutical industry representative 3
  Clinical nurse 1